Shares of Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.16 and traded as high as $0.33. Cell MedX shares last traded at $0.32, with a volume of 3,953 shares changing hands.
Cell MedX Stock Performance
The company’s 50-day simple moving average is $0.37 and its 200-day simple moving average is $0.16.
Cell MedX Company Profile
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Featured Stories
- Five stocks we like better than Cell MedX
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- MP Materials: Rare Earth Elements Powering the EV Boom
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- How to Invest in Biotech Stocks
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
